Duplicate detection in adverse drug reaction surveillance


The WHO Collaborating Centre for International Drug Monitoring in Uppsala, Sweden, maintains and analyses the world’s largest database of reports on suspected adverse drug reaction (ADR) incidents that occur after drugs are on the market. The presence of duplicate case reports is an important data quality problem and their detection remains a formidable challenge, especially in the WHO drug safety database where reports are anonymised before submission. In this paper, we propose a duplicate detection method based on the hit-miss model for statistical record linkage described by Copas and Hilton, which handles the limited amount of training data well and is well suited for the available data (categorical and numerical rather than free text). We propose two extensions of the standard hit-miss model: a hit-miss mixture model for errors in numerical record fields and a new method to handle correlated record fields, and we demonstrate the effectiveness both at identifying the most likely duplicate for a given case report (94.7% accuracy) and at discriminating true duplicates from random matches (63% recall with 71% precision). The

Niklas Norén,   Roland Orre,   Andrew Bate,   I.R. Edwards
Last modified: Mon Jun 2 16:36:20 CEST 2008